Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07383974

The Impact of 12 Week Retention of Nutrients on Skin and the Perception of Physical Health Status

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
ChinaNorm · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This is a randomized, double-blind, placebo-controlled clinical trial exploring the effects of a 12-week dietary supplement regimen on skin condition and perceived overall health status. The study will involve 120 healthy Chinese adults aged 18 and above with low daily fruit and vegetable intake. Participants will be randomly assigned to one of two groups: one group will take a combination of Nu Skin's Vitamin C \& Green Tea Capsules and Multivitamin \& Mineral Capsules, while the other group will take a matching placebo. The primary goal is to assess if the supplement combination improves skin health after 12 weeks, measured through specialized facial imaging (assessing spots, redness, evenness) and probe measurements (assessing elasticity, moisture, gloss). Secondary goals include evaluating changes in participants' self-perceived health status (via quality of life, fatigue, and digestive health questionnaires), psychological resilience, memory, and exploring a new method for measuring skin carotenoid levels. This study is not intended to verify the approved health functions of the products but to explore the potential combined effects of antioxidant and nutritional supplementation on skin and general well-being.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTVitamin C & Green Tea Capsules + Multivitamin & Mineral Capsules CombinationParticipants take a combination of active supplements-specifically, Vitamin C \& Green Tea Capsules and Multivitamin \& Mineral Capsules-orally twice daily.
DIETARY_SUPPLEMENTPlacebo Combination (Matching)Participants take a matching placebo combination (identical in appearance and taste to the active supplements) orally twice daily

Timeline

Start date
2025-11-03
Primary completion
2026-02-02
Completion
2026-02-02
First posted
2026-02-03
Last updated
2026-02-03

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07383974. Inclusion in this directory is not an endorsement.